Immune-monitoring in Kawasaki disease patients treated with infliximab and intravenous immunoglobulin

Clinical and Experimental Immunology

Volumn 174, Issue 3, 2013, Pages 337-344

  Burns, J C ^a   Song, Y ^a   Bujold, M ^a   Shimizu, C ^a   Kanegaye, J T ^a   Tremoulet, A H ^a   Franco, A ^a  

^a RADY CHILDREN'S HOSPITAL   (United States)

Author keywords

Dendritic cells; Infliximab; Kawasaki disease; T cells; Vascular inflammation

Indexed keywords

CD86 ANTIGEN; IMMUNOGLOBULIN; INFLIXIMAB; TUMOR NECROSIS FACTOR ALPHA;

ADD ON THERAPY; ADOLESCENT; ADULT; ANTIGEN PRESENTATION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; CORONARY ARTERY ANEURYSM; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; IMMUNOLOGICAL MONITORING; MALE; MEMORY T LYMPHOCYTE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYELOID DENDRITIC CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGULATORY T LYMPHOCYTE;

DENDRITIC CELLS; INFLIXIMAB; KAWASAKI DISEASE; T CELLS; VASCULAR INFLAMMATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; ANTIGENS, CD86; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; CORONARY ANEURYSM; DENDRITIC CELLS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; IMMUNOLOGIC MEMORY; INFANT; INFLAMMATION; LYMPHOCYTE COUNT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYELOID CELLS; PLACEBOS; T-LYMPHOCYTES, REGULATORY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84886266248     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12182     Document Type: Article

References (12)

1. Kawasaki T, Kosaki F, Okawa S etal. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974; 54:271-276.
2. Franco A, Shimizu C, Tremoulet AH etal. Memory T-cells and characterization of peripheral T-cell clones in acute Kawasaki disease. Autoimmunity 2010; 43:317-324.
3. Burns JC, Best BM, Mejias A etal. Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease. Pediatrics 2008; 153:833-838.
4. Nie H, Zheng Y, Li R etal. Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-alpha in rheumatoid arthritis. Nat Med 2013; 19:322-328.
5. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994; 179:1109-8.
6. Onouchi Y, Gunji T, Burns JC etal. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet 2008; 40:35-42.
7. Gregori S, Magnani CF, Roncarolo MG. Role of human leukocyte antigen-G in the induction of adaptive type 1 regulatory T cells. Hum Immunol 2009; 70:966-969.
8. Gregori S, Tomasoni D, Pacciani V etal. Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. Blood 2010; 116:935-944.
9. Amodio G, Mugione A, Sanchez AM etal. HLA-G expressing DC-10 and CD4(+) T cells accumulate in human decidua during pregnancy. Hum Immunol 2013; 74:406-411.
10. Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 2004; 22:745-763.
11. Smolewska E, Stańczyk J, Brózik H etal. Distribution and clinical significance of blood dendritic cells in children with juvenile idiopathic arthritis. Ann Rheum Dis 2008; 67:762-768.
12. Heinze A, Elze MC, Kloess S etal. Age-matched dendritic cell subpopulations reference values in childhood. Scand J Immunol 2013; 77:213-220.